Travers Smith LLP has advised the management team of LGC in relation to the acquisition of LGC by a consortium led by Cinven and Astorg, from KKR and management. The Travers team has a long-standing relationship with LGC, having acted for management when KKR acquired the business in 2015.
LGC provides a comprehensive range of measurement tools, proficiency testing schemes, supply chain assurance standards and specialty genomics reagents underpinned by leading analytical and measurement science capabilities. Its scientific tools and solutions form an essential part of its customers’ quality assurance procedures and enable organisations to develop and commercialise new scientific products and advance research. The company serves customers across a number of end markets, including human healthcare, agri-food and the environment. LGC has its headquarters near London and employs over 3,200 employees across 22 countries.
The Travers Smith team was led by Private Equity and Financial Sponsors Partner Adam Orr, assisted by Senior Associate Richard Hornshaw and associates James Ravden and Shannon Anstee. Tax advice was provided by Partner Russell Warren and Associate Kaleem Khan.
KKR was advised by Simpson Thacher and the consortium was advised by Latham & Watkins.